Indicators of carbohydrate metabolism in a patient with dyslipidemia and impaired fasting glycemia receiving pitavastatin: a case report-Reference-Cited by-同舟云学术

Indicators of carbohydrate metabolism in a patient with dyslipidemia and impaired fasting glycemia receiving pitavastatin: a case report

Published:2023-01-17 Issue:12 Volume:21 Page:3496
ISSN:2619-0125
Container-title:Cardiovascular Therapy and Prevention
language:
Short-container-title:Cardiovasc Ther Prev

Author:

Nekrasov A. A.¹^ORCID,Timoshchenko E. S.²^ORCID,Cherneva D. V.²,Volovatova I. N.³^ORCID,Nekrasova T. A.³^ORCID

Affiliation:

1. Volga Research Medical University; City Clinical Hospital № 5

2. City Clinical Hospital № 5

3. Volga Research Medical University

Abstract

Statins have diabetogenic properties. Pitavastatin is currently considered the only drug in this group that combines high lipid-correcting activity with the absence of a negative effect on carbohydrate metabolism. The article presents a case of correction of carbohydrate metabolism indicators against the background of pitavastatin therapy in a patient with dyslipidemia and impaired fasting glycemia. The optimal algorithms for the examination and treatment of such patients are discussed on the example of this patient.

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine,Education

Reference22 articles.

1. Verbovoy AF, Verbovaya NI, Dolgikh YuA. Obesity is the basis of metabolic syndrome. Obesity and metabolism. 2021;18(2):142-9. (In Russ.) doi:10.14341/omet12707.

2. German CA, Baum SJ, Ferdinand KC, et al. Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology. Am J Prev Cardiol. 2022;12:100432. doi:10.1016/j.ajpc.2022.100432.

3. Alferova VI, Mustafina SV. The prevalence of obesity in the adult population of the Russian Federation (literature review). Obesity and metabolism. 2022;19(1):96-105. (In Russ.) doi:10.14341/omet12809.

4. Badin YuV, Fomin IV, Belenkov YuN, et al. EPOCHA-AH 1998-2017. Dynamics of prevalence, awareness of arterial hypertension, treatment coverage, and effective control of blood pressure in the European part of the Russian Federation. Kardiologiia. 2019;59(1S):34-42. (In Russ.) doi:10.18087/cardio.2445.

5. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. 2022 Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):3235. (In Russ.) doi:10.15829/17288800-2022-3235.